Shares outstanding · 2013–2025

Akebia Therapeutics shares outstanding

265M+18.0% · FY2025

Akebia Therapeutics (AKBA) reported 265M in shares outstanding for fiscal 2025, +18.0% year on year.

1.4M201320.4M201430.7M201538.6M201647.6M2017117M2018122M2019148M2020177M2021184M2022195M2023225M2024265M2025
Akebia Therapeutics — Shares outstanding, 2013–2025
Fiscal yearShares outstandingChangeFiling
FY20252025-12-31265M+18.0%Open →
FY20242024-12-31225M+15.6%Open →
FY20232023-12-31195M+5.7%Open →
FY20222022-12-31184M+4.0%Open →
FY20212021-12-31177M+19.5%Open →
FY20202020-12-31148M+21.7%Open →
FY20192019-12-31122M+4.1%Open →
FY20182018-12-31117M+145.5%Open →
FY20172017-12-3147.6M+23.3%Open →
FY20162016-12-3138.6M+25.9%Open →
FY20152015-12-3130.7M+50.5%Open →
FY20142014-12-3120.4M+1,372.6%Open →
FY20132013-12-311.4M—Open →

Shares outstanding — Shares outstanding is the number of shares in issue at the reporting date. A falling count usually means the company is buying back stock; a rising one means it is issuing.

Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2013–2025 compound annual growth +55.0%

Shares outstanding at companies of similar size

Cite this page

Ready-made references for the figures on this page, as published on September 25, 2026.

Wikipedia

{{cite web |title=Akebia Therapeutics shares outstanding |url=https://companiesranked.com/en/company/akebia-therapeutics/shares-outstanding |website=CompaniesRanked |date=2026-09-25 |language=en}}

APA 7

CompaniesRanked. (September 25, 2026). Akebia Therapeutics shares outstanding. CompaniesRanked. https://companiesranked.com/en/company/akebia-therapeutics/shares-outstanding

BibTeX

@misc{companiesranked-en-company-akebia-therapeutics-shares-outstanding-2026,
  author       = {{CompaniesRanked}},
  title        = {{Akebia Therapeutics shares outstanding}},
  year         = {2026},
  howpublished = {\url{https://companiesranked.com/en/company/akebia-therapeutics/shares-outstanding}},
  note         = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
  urldate      = {2026-09-25}
}

The filing itself

The numbers above are read from this document: 10-Q · 0001517022-26-000051 · August 5, 2026

{{cite web |title=Akebia Therapeutics shares outstanding — 10-Q (0001517022-26-000051) |url=https://www.sec.gov/Archives/edgar/data/1517022/000151702226000051/akba-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-05}}

The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.

← Akebia Therapeutics overview